Developments in the Cell Therapy/Gene Therapy Space

From CRISPR-Cas9 to iPSCs and mRNA inhibitors, cell and gene therapies represent the cutting edge of innovation. While this exciting and rapidly developing field continues to revolutionize the pharmaceutical and biotechnology industry, it also presents unique legal and regulatory challenges. Please join us for a discussion of some of the key legal and regulatory issues impacting the cell and gene therapy space.

Topics will include:

• Overview of cell and gene therapy space
• Key considerations in structuring cell and gene therapy transactions
• Latest developments in regulatory framework for cell and gene therapy
• Hot topics in IP landscape for cell and gene therapy

Questions?

For more information, please contact Erin Beck.